Capsule colonoscopy increases uptake of colorectal cancer screening by unknown
Groth et al. BMC Gastroenterology 2012, 12:80
http://www.biomedcentral.com/1471-230X/12/80RESEARCH ARTICLE Open AccessCapsule colonoscopy increases uptake of
colorectal cancer screening
Stefan Groth1,2, Horst Krause1,2, Rainer Behrendt1,2, Helge Hill1,2, Michael Börner1,2, Murat Bastürk1,2,
Nora Plathner1,2, Friedrich Schütte1,2, Ulrich Gauger1,2, Jürgen Ferdinand Riemann1,2, Lutz Altenhofen1,2
and Thomas Rösch1,2,3*Abstract
Background: Screening colonoscopy effectiveness is hampered by limited adherence by the general population.
The present prospective study was performed to evaluate whether adding capsule colonoscopy to the endoscopic
screening options increases uptake.
Methods: Invitation letters were sent to 2150 persons above the age of 55 insured with a German medical
insurance company in the area of Rinteln, Lower Saxony with a baseline spontaneous annual screening
colonoscopy uptake of 1 %. Both capsule or conventional colonoscopy were offered. Interested persons were given
information about the two screening options by four local gastroenterologists and examinations were then
performed according to screenees’ final choice.
Results: 154 persons sought further information, and 34 and 90 underwent conventional and capsule colonoscopy,
respectively. Colonoscopy uptake was thus increased by the invitation process by 60 % (1.6 % vs. 1 %; p = 0.075),
while the option of capsule endoscopy led to a fourfold increase of screening uptake (4.2 % vs. 1 %, p< 0.001).
Despite similar age distribution in both sex groups, uptake in men was significantly higher (5.6 % vs. 2.8 %, p = 002).
However, overall adenoma yield was not different in both groups.
Conclusions: The present study suggests that offering the option of capsule colonoscopy increases uptake of
endoscopic colorectal cancer screening. However, capsule endoscopy sensitivity for adenoma detection needs to
be improved.
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There is adequate evidence that colorectal cancer (CRC)
screening by various methods prolongs survival for those
screened [1-3], and although this evidence is only indir-
ect with regard to screening colonoscopy, the latter has
been included in the CRC screening programmes of
countries such as the USA and Germany. In Germany,
screening colonoscopy is generally reimbursed for per-
sons over the age of 55 years [4] with an annual uptake* Correspondence: t.roesch@uke.de
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reproduction in any medium, provided the orof about 3 % [5]. Although colonoscopy is generally
open to all insured persons 55 years or older, no invita-
tion or reminder system exists in Germany and uptake
depends on the initiative and interest of general practi-
tioners, gynaecologists, urologists and other specialists,
who refer patients interested in CRC screening to gas-
troenterologists. A variety of media campaigns [6] and
other initiatives have led to only small and brief bursts
of interest. The reasons for the limited take-up of CRC
screening, especially of colonoscopy, are diverse and not
fully known; some recent studies have looked into the
issue of barriers to CRC screening in general, the accept-
ability of various tests and potential measures to im-
prove participation [7-16]. Apart from general doubts
and fears, factors such as perception of faecal occulttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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painful may have contributed to the lack of uptake.
Capsule endoscopy was introduced some years ago pri-
marily for small bowel diagnostics, but has been extended
to the colon with a modified capsule used for capsule col-
onoscopy. Capsule colonoscopy has been shown to be
about 65 %-75 % accurate for adenoma detection in the
large bowel when compared with colonoscopy, with better
results for a more recent colon capsule version [17-20]. It
could be speculated that the use of this new technology,
although still requiring bowel cleaning, might attract more
people potentially interested in CRC screening.
Therefore, the present prospective study evaluated the
uptake of capsule as an alternative to conventional col-
onoscopy when offered to insured persons in the frame-
work of invited CRC screening.
Patients and methods
Study partners
The study was designed and supervised by the Depart-
ment of Interdisciplinary Endoscopy, University Hospital
Hamburg-Eppendorf (S.G., TR), and executed by four
local gastroenterologists in private practice (R.B., H.H., M.
B., M.B.), supported by a hospital-based gastroenterologist
(H.K.) with previous experience in capsule colonoscopy, in
the area of Rinteln, Hameln and Wunsdorf, Lower Saxony,
Germany, in close cooperation with a regional medical in-
surance company (BKK24). This area south of Hannover
has a population of 1 307 568 (source: www.meinestadt.
de), and BKK 24 has 14 304 insured persons in this area,
3091 of whom were above the age of 55 in 2009. About
75 % of all persons insured with BKK 24 in Lower Saxony
were living in the study area (see below). The study was
approved by the IMDEC GmbH Ethical Committee,
Freiburg (31.3.2009).
CRC uptake in the Rinteln area
In Germany, since the end of 2002, persons above the age
of 55 who have not undergone colonoscopy in the preced-
ing 10 years are entitled to a screening colonoscopy (which
can be repeated after 10 years if negative), without an exist-
ing invitation or reminder programme. The nationwide
current annual uptake of screening colonoscopy is around
3 % [5]. According to BKK 24 data for the Rinteln area, the
uptake of screening colonoscopy in Lower Saxony among
their insured persons above the age of 55 has been 1.02 %
for the last 3 years before the start of the study, and was set
at 1 % for study purposes. This uptake is lower than on Na-
tional average in Germany according to data from the Na-
tional screening colonoscopy registry [6].
Organisation of the present study
At the beginning of the study an introductory meeting
was held to guarantee acceptance by all the medicalpartners in the area, and for discussion and agreement
on similar consultation procedures (a summary of bullet
points was provided for the informed consent) for the
persons showing an interest who responded to the BKK
24 invitation letters. Balanced informed consent about
pros and cons of colonoscopy versus capsule endoscopy
was agreed upon. The 4 gastroenterologists underwent
special training in performance and reading of capsule
colonoscopy. Invitation letters were sent out by the BKK
24 medical insurance company to a total of 2150 eligible
persons in the area of Rinteln and surrounding cities,
with about 25 % each invited in the spring and summer
of 2009 and about 50 % in the autumn, starting in Rin-
teln (where the participating gastroenterologists were
located) and subsequently involving people living but
within 50 km.
Persons opting to undergo colonoscopy gave informed
consent and underwent standard lavage regimens for colon
preparation. Those willing to undergo capsule colonoscopy
(Pillcam Colon 1, Given Imaging Corp. Hamburg/Germany)
were provided with a detailed information sheet about cap-
sule accuracy and the need for repeat colonoscopy if positive
(including preparation) as well as about capsule-specific
bowel preparation, as described fully elsewhere [17,18]. If
polyps were found, capsule patients were re-invited for col-
onoscopy. In case of insufficient bowel preparation for ad-
equate capsule reading or incomplete passage of the large
bowel, patients were also offered colonoscopy. Study partici-
pants were given questionnaires before and after an initial
meeting with the gastroenterologist, with items about their
motivation and their decision for either capsule or conven-
tional colonoscopy. The non-responders could not be con-
tacted for their motivation not to participate for data safety
reasons.
Outcome parameters
The main outcome parameter was the potential increase
in the rate of persons accepting conventional or capsule
colonoscopy among all persons invited compared with
the mean annual uptake of colonoscopy in the preceding
3 years (1 %, see above).
Secondary outcome parameters were
 Adenoma yield in both groups, namely the capsule
group including those participants with subsequent
colonoscopy, and the group with capsule
colonoscopy only
 Rate of capsule examinations with sufficient bowel
preparation (grading was done on a 4-point scale in
accordance with previous studies [17,18]
 Adverse events and complications in both arms of
the study
 Patient opinion and acceptability according to the
questionnaires mentioned above
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No precise case number calculation could be made since
this was the first study of its kind focusing on uptake
when an alternative to colonoscopy was available. The
current annual acceptance rate for screening colonos-
copy in Germany is around 3 %, in the Rinteln area it is
2.2 %, and among persons insured with BKK 24 it is
around 1 % (see above). Thus, a significant difference in
uptake, for a one-sided comparison, would be reached at
an increased uptake of 1.6 % versus 1 % (p = 0.045), and
for a two-sided comparison at 1.7 % (p = 0.049).Results
General acceptance and uptake
Up to December 31st 2009, 2150 letters (49.3 % to men,
and 51.7 % to women) had been mailed to insured persons
insured with BKK 24 in the Rinteln area who were over
55 years of age and eligible for CRC screening in Lower
Saxony. Of those, 154 persons (88 men, 66 women, mean
age 63.5 years, SD 6.2) contacted one of the 4 gastroenter-
ologists named in the letter and presented for a personal
interview. After this discussion and reading the standar-
dized informed consent, 7 were excluded since they were
not eligible for screening, and 124 of the remaining 147
persons decided to undergo either colonoscopy (n= 34) or
capsule (n= 90), while 23 finally opted against both forms
of endoscopic screening. Details are shown in Figure 1.
The mean age of the screenees was 63.3 years in the col-
onoscopy group and 62.7 in the capsule endoscopy group;
the percentage of men was higher in the capsule group
(64.4 % vs. 47.1 % for colonoscopy).
There were 39 persons undergoing screening colonos-
copy outside of the project during the study period who
were insured with BKK 24. 35 of those had received the
invitation letters but did not seek further information as
offered within the project; for these people it is not clear
whether they were prompted by the invitation letter
since IRB-based data protection did not allow for identi-
fication of individuals and a timewise correlation of invi-
tation letter and colonoscopy. It was decided to count
these 39 persons as the spontaneous uptake group which
would correspond to a figure of 1.3 % instead of 1 %
observed in the years before (which was set as back-
ground uptake).
Thus, the uptake of any endoscopic screening test (cap-
sule or conventional colonoscopy) stimulated by the pro-
ject invitation letters was 5.8 % (124/2150), with 34 (1.6 %)
opting for primary colonoscopy and 90 (4.2 %) choosing
primary capsule endoscopy. Comparing these rates to the
spontaneous rate set at 1 %, the increase was 60 % for col-
onoscopy (1.6 % versus 1 %, p = 0.075; two sided compari-
son) and more than 4 fold - 420 % (4.2 % versus 1 %;
p< 0.001) – for capsule colonoscopy. Regarding sexdistribution, uptake was 5.6 % in men and 2.8 % in women
(p= 0.002).
Reading and bowel cleanliness in the capsule group
Bowel cleanliness was graded excellent in none, and good
in 28, moderate in 45 and poor in 11 cases (12.2 %). Incom-
plete colonic capsule passage was found in 15/89 cases, and
in 7 of those the rectum was reached. In one case spontan-
eous passage through the colon occurred before the capsule
was activated. Thus, full colonic visualization on the basis
of complete capsule passage was possible in 73/89 cases
(82 %).
Adenoma yield
These data are shown in Figure 1. Overall, 9 patients with
13 low-grade adenomas (all <1 cm) were found in the
colonoscopy group. This accounts for a patient rate with at
least one adenoma of 26.4 % (confidence limits [CL]
12.9 %, 44.4 %) and an adenoma rate (all adenomas/all
patients) of 38.2 % (CL 22.2 %, 56.4 %); this difference was
statistically significant (p= 0.018, Fisher exact tests, two
sided). Adenomas in the capsule group were only counted
if confirmed by colonoscopy with biopsy or polypectomy.
In this group, 16 patients underwent colonoscopy because
of positive capsule findings suggesting polyps; in addition,
6/15 with incomplete capsule endoscopy followed the
recommendation to undergo colonoscopy. Of these 22
patients overall, 8 cases were identified who had a total of
14 adenomas (of those, 5 were 1 cm or greater) in the cap-
sule group. In summary, the patient rate with at least one
adenoma for capsule colonoscopy, based on secondary
colonoscopy results, was 9 % (8/90; CL 4.7 %, 18.1 %), and
the adenoma rate (all adenomas/all cases) was 15.5 % (CL
8.8 %, 24.7 %). Also this difference was statistically signifi-
cant (p= 0.013, Fisher exact tests, two sided)
Adverse events
There were no reported adverse events in any of the
study participants.
Patient opinion and acceptability
147 persons undergoing capsule and/or conventional colon-
oscopy within the project responded to the questionnaires
(Table 1). The interest in endoscopic CRC screening was
aroused by the BKK invitation (85.5 %), followed by recom-
mendation from a general physician (19.7 %). Amongst
those persons who eventually underwent one of the two
tests, the main reason for a final choice of capsule was the
fear of colonoscopy-related discomfort and complications,
while the main reason for choosing colonoscopy was the
possibility for taking tissue samples and carrying out
polypectomy.
The acceptability of the different procedures as per-
ceived after the examinations was investigated. Among
            no previous colonoscopy 
Invitation to 2150 insured persons 941 uninvited persons 
> age 55 >  5 5 years
No pr evious colonoscopy in last 10 yea rs
2150 lett ers sent out (70 %  o f eligible persons)
154 persons: personal appointment no patient contact 
for information with physician (project)  for prior information 
N= 147 after exclusion criteria    colonoscopy   n=4  spontaneous   
         outside of project    uptake 
n=35 n=3 9/293 7*
(1.3% )
No screening  capsule   conventional   overall screening 
N=23   colonoscopy (CC) colonoscopy (CO)   CC and CO  
N=90  (4.2%)  N=34  (1.6%)   124/2150 (5.8%)
Second ary colonoscopy** 
N= 22
14 adenoma s (LGIN)    13 adenomas (LGIN) 
* See text; it is not clear to what extent the 35 persons 
were prompted by the invitation letters. 
2937= 3091 (all insured persons) minus 154 project 
participants 
** 16 cases with polyps found at capsule procedure; 
6/15 cases with incomplete capsule colonoscopy (see 
text) 
Figure 1 Flow sheet of study procedure and outcome of participants and other screening colonoscopies in 2009.
Table 1 Results of patient questionnaire; multiple
positive responses were possible for each item
Reasons for general interest in colorectal cancer screening
(n = 147)*
I think prevention is generally important 11175.5 %
My general physician recommended screening 29 19.7 %
Mainly due to the invitation by BKK 24 12585.0 %
Since capsule colonoscopy is free 52 35.4 %
Others 8 5.4 %
Reasons to choose capsule colonoscopy (n= 89)**
Sounds more pleasant 82 92.1 %
I am afraid of colonoscopy pain 10 11.2 %
I am afraid of sedation 4 4.5 %
I am afraid of colonoscopy complications 11 12.4 %
Others 2 2.2 %
Reasons to choose colonoscopy (n= 37)**
Colonoscopy is the standard method 8 21.6 %
Colonoscopy enables biopsy and polypectomy 31 83.8 %
Others 2 5.4 %
*from questionnaire before the interview with physician.
**from questionnaire after the interview with physician.
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whether capsule colonoscopy would be again the method
of choice for repeated colonic examination, 65 %
answered “yes” and 22 % “probably yes”, after capsule col-
onoscopy. The corresponding values for colonoscopy
were 94 % and 0 %. Of the 22 persons who underwent
colonoscopy after capsule, 16 answered the questionnaire
and 11 stated they would choose conventional colonos-
copy for a repeat examination, mainly because everything
could be done in one procedure and colonoscopy was felt
to be more accurate. Two further persons said that they
would probably choose capsule rather than conventional
colonoscopy.
Discussions
The present study for the first time analyses the effect of
offering a new examination method on the uptake of CRC
screening. In Germany, CRC screening by colonoscopy is
based on spontaneous uptake and no invitation system
exists as yet. In our study we were able to show that in
addition to the presumed invitation effect – which per se
led to an increase in colonoscopy rate by about 60 % – a
fourfold increase in endoscopic screening could be attrib-
uted to the offer of capsule colonoscopy, with men in par-
ticular finding capsule colonoscopy more acceptable.
However, the overall adenoma yield was not different in
the two examination groups, although all patients withpositive capsule findings and 40 % with incomplete capsule
examination underwent secondary conventional colonos-
copy. This points towards a need to improve capsule
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for implementation into a CRC screening programme.
Our study results deserve several comments which
have only partly to do with limitations of the present
study:
1. Uptake was rather low even under study conditions
using an invitation process; however, uptake within
the German opportunistic screening programme is
generally limited (around 3 % annually) but was
lower in the study area in the years preceding the
study (1 %). It could be that the effect of offering
capsule endoscopy may be less pronounced in areas
with higher uptake, but this would have to be
studied.
2. We performed a single-arm rather than a
randomized study; from a purely scientific
standpoint, only the latter, randomizing patients to
being invited to either colonoscopy or capsule
endoscopy would have enabled us to clearly
differentiate between the invitation effect and the
effect of offering a new technique. Nevertheless, our
design mirrored the reality where often more than
one options are offered. A further limitation to
generalize our result was that only one patient group
covered by one insurance was included in our study.
3. In the literature, direct comparisons of spontaneous
versus invited screening colonoscopy uptake rates
are not available, since it is difficult to measure the
spontaneous uptake outside of a programme.
However, there is ample indirect evidence that
invitation methods increase uptake, and there are
also randomized and other studies showing that
more intensive invitation measures and the
involvement of general practitioners in the invitation
process lead to greater uptake [21-25]. In our study,
for reasons of data protection, 35 persons who
underwent colonoscopy and who also had received
invitation letters, but did not enter the project and/
or sought information from one of the 4 project
gastroenterologists, were not counted as study
participants since their individual data could not be
used. We decided that these cases would not be
counted among the persons with concomitant
spontaneous uptake. If we did this, the uptake
increase would have been much higher for
colonoscopy, further underlining the importance of
an invitation process. Naturally, screening behavior
would furthermore be different in setting with free
access to the respective screening test versus self-
paid methods; since colonoscopy is reimbursed over
the age of 55 (without colonoscopy in the
preceeding 10 years), we think that free access to
capsule colonoscopy allowed for a fair comparison inthe German setting. Very likely, this would change
with changing reimbursement strategies.
4. Data on adenoma yield by capsule colonoscopy was
disappointing, although our study was not powered
to show differences in polyp yield. Firstly, it was
noteworthy that all persons with polyps detected on
capsule endoscopy also agreed to undergo secondary
colonoscopy; in the group with incomplete capsule
endoscopy, this rate was lower but still relevant
(40 %). In the recent large multicenter trial on
capsule endoscopy controlled by conventional
colonoscopy, sensitivity for polyps less than 1 cm
was only slightly over 60 % [19]. Thus, it is
conceivable that under routine conditions as in our
study, sensitivity can be even lower; we think that
sensitivity would have to be substantially improved
before capsule colonoscopy would be an option for
CRC screening. Polyps also tended to be smaller in
the colonoscopy group which might be related to
the lower sensitivity of capsule for smaller polyps
[19]. It appears possible that this would be the case
with the second generation colon capsules [20,26],
but this would have to be proven in either a similar
study and/or a comparative trial
5. The offer of capsule endoscopy had a much better
effect on uptake in men than in women. Men are
known to have a lower uptake than women of
colorectal screening measures, at least in Germany
[27]: a detailed analysis of colonoscopy screening
participation in Germany shows a 10 % lower uptake
of screening colonoscopy by men, which is increased
in the age groups below 70 [5]. Experiences from
other countries are however variable and more
difficult to predict [28,29]. Our results show that
men might be better motivated by the offer of this
new technology, but these results are of course
preliminary. The durability and reproducibility of
such effects at repeated investigation is not known
either.
In our study, a ‘one-stop shop’ process – using one co-
lonic preparation for capsule endoscopy, followed by
colonoscopy in case of lesions, requiring very rapid read-
ing - was not attempted or done (and this was explained
to patients during informed consent). Patients with posi-
tive or doubtful findings therefore had to undergo a sec-
ond bowel preparation. This may be regarded as
drawback of capsule endoscopy, even if it only applies to
20 %–30 % of patients. In previous capsule studies where
colonoscopy was used as the gold standard in all cases,
such as in the large multicenter trial [19], the protocol
included a single preparation for capsule plus colonos-
copy procedures, but this did not include patient selec-
tion for colonoscopy by capsule as a filter test when
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time of colonoscopy. It may be quite difficult to establish
such programmes of capsule endoscopy, with perform-
ance and reading, plus colonoscopy, all routinely done in
1 day. Further studies have to show how such ambitious
programmes might possibly be implemented, for ex-
ample by fast central reading services and an on-call col-
onoscopy service for screenees with polyps identified by
the capsule, and whether such programmes might fur-
ther increase uptake. Only if larger and stable numbers
of capsule colonoscopies should ever be performed, and
regarded as economically viable, might such a service
appear more realistic. It will then also become more evi-
dent to which degree uptake is influenced by other fac-
tors such as capsule performance (sensitivity, need to
still undergo colonoscopy) and logistical issues (such as
one-stop shopping).
Conclusions
The present study showed that uptake of colorectal screening
can be increased by offering capsule endoscopy in addition
to colonoscopy. These interesting new results with regards
acceptance as well as performance of capsule colonoscopy as
a screening option in daily routine can form the basis of fur-
ther studies. In particular, capsules with increased sensitivity
such as those from the second generation should be used for
further larger and preferentially randomized studies to match
uptake with outcome with respect to adenoma detection.
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